miR-214-3p promotes the pathogenesis of Parkinson's disease by inhibiting autophagy
Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved..
Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by dopaminergic neuron death in the substantia nigra, leading to motor dysfunction. Autophagy dysregulation has been implicated in PD pathogenesis. This study explores the role of miR-214-3p in PD, focusing on its impact on autophagy and dopaminergic neuron viability. Using in vitro and in vivo models, we demonstrate that miR-214-3p inhibits autophagy and promotes dopaminergic neuron apoptosis. Behavioral assessments and molecular analyses reveal exacerbation of PD symptoms upon miR-214-3p overexpression. Furthermore, mechanistic investigations identify ATG3 as a target, shedding light on miR-214-3p's regulatory role in autophagy. These findings enhance our understanding of PD pathogenesis and propose miR-214-3p as a potential biomarker and therapeutic target for modulating autophagy and neuronal survival in PD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:171 |
|---|---|
| Enthalten in: |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 171(2024) vom: 07. Feb., Seite 116123 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dong, Hui [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ATG3 |
|---|
| Anmerkungen: |
Date Completed 08.02.2024 Date Revised 08.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.biopha.2024.116123 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367019736 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367019736 | ||
| 003 | DE-627 | ||
| 005 | 20240208232026.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.biopha.2024.116123 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1284.xml |
| 035 | |a (DE-627)NLM367019736 | ||
| 035 | |a (NLM)38211424 | ||
| 035 | |a (PII)S0753-3322(24)00004-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dong, Hui |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a miR-214-3p promotes the pathogenesis of Parkinson's disease by inhibiting autophagy |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.02.2024 | ||
| 500 | |a Date Revised 08.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved. | ||
| 520 | |a Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by dopaminergic neuron death in the substantia nigra, leading to motor dysfunction. Autophagy dysregulation has been implicated in PD pathogenesis. This study explores the role of miR-214-3p in PD, focusing on its impact on autophagy and dopaminergic neuron viability. Using in vitro and in vivo models, we demonstrate that miR-214-3p inhibits autophagy and promotes dopaminergic neuron apoptosis. Behavioral assessments and molecular analyses reveal exacerbation of PD symptoms upon miR-214-3p overexpression. Furthermore, mechanistic investigations identify ATG3 as a target, shedding light on miR-214-3p's regulatory role in autophagy. These findings enhance our understanding of PD pathogenesis and propose miR-214-3p as a potential biomarker and therapeutic target for modulating autophagy and neuronal survival in PD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ATG3 | |
| 650 | 4 | |a Autophagy | |
| 650 | 4 | |a Dopaminergic neurons | |
| 650 | 4 | |a Parkinson's disease | |
| 650 | 4 | |a miR-214–3p | |
| 650 | 7 | |a MicroRNAs |2 NLM | |
| 650 | 7 | |a MIRN214 microRNA, human |2 NLM | |
| 700 | 1 | |a Yan, Jiahui |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Ping |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Xinyu |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Ru |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Caiyun |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Wenhui |e verfasserin |4 aut | |
| 700 | 1 | |a Qian, Wenxian |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Jin |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Yunli |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Jinghan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Mengmeng |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Xiuchang |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Zhizhong |e verfasserin |4 aut | |
| 700 | 1 | |a Yi, Changhua |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Jie |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Wei |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |d 1984 |g 171(2024) vom: 07. Feb., Seite 116123 |w (DE-627)NLM012645591 |x 1950-6007 |7 nnns |
| 773 | 1 | 8 | |g volume:171 |g year:2024 |g day:07 |g month:02 |g pages:116123 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.biopha.2024.116123 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 171 |j 2024 |b 07 |c 02 |h 116123 | ||